U.S. markets open in 3 hours 25 minutes
  • S&P Futures

    4,401.00
    -13.25 (-0.30%)
     
  • Dow Futures

    34,894.00
    -140.00 (-0.40%)
     
  • Nasdaq Futures

    15,098.75
    -19.00 (-0.13%)
     
  • Russell 2000 Futures

    2,198.40
    -15.00 (-0.68%)
     
  • Crude Oil

    72.04
    +0.13 (+0.18%)
     
  • Gold

    1,796.70
    -2.50 (-0.14%)
     
  • Silver

    25.22
    -0.10 (-0.41%)
     
  • EUR/USD

    1.1784
    -0.0024 (-0.20%)
     
  • 10-Yr Bond

    1.2760
    0.0000 (0.00%)
     
  • Vix

    18.71
    +1.51 (+8.78%)
     
  • GBP/USD

    1.3774
    -0.0050 (-0.36%)
     
  • USD/JPY

    110.1340
    -0.2410 (-0.22%)
     
  • BTC-USD

    37,356.51
    -890.61 (-2.33%)
     
  • CMC Crypto 200

    886.86
    -28.63 (-3.13%)
     
  • FTSE 100

    6,987.11
    -38.32 (-0.55%)
     
  • Nikkei 225

    27,970.22
    +136.93 (+0.49%)
     

Orphazyme stock's rocket ride leads to 20 volatility halts, Galecto stock halted 7 times

·1 min read
Orphazyme stock's rocket ride leads to 20 volatility halts, Galecto stock halted 7 times

Shares of Orphazyme A/S blasted 383.8% higher, enough to make the Denmark-based biopharmaceutical company's stock by far the biggest gainer listed on major U.S. exchanges, prior to a trading halt. The stock, which was up as much as 1,387% at its intraday high of $77.77, was halted for volatility for the 20th time Thursday at 3:24 p.m. Eastern with the last trade at $25.30, and remains halted. The stock's rally gave the company a market capitalization of $884.3 million. The company confirmed that